is semaglutide legal Why Being Banned? The GLP-1 RA Legal Timeline:

Danish diabetes and obesity giant Novo Nordisk (NOV: N) today announced headline results from STEP UP, a Phase IIIb trial in the global STEP program, in a further bid to cement its dominance of the weight-management sector

Gareth E, Lim L, Patricia L Brubaker

These actions targeted businesses operating as 503B outsourcing facilities without proper licensing, compounding medications without valid prescriptions, and making unsubstantiated efficacy claims

The extended release of these compounds creates a durable 'off' signal for appetite, unlike quick-digesting meals that produce brief satisfaction followed by rapid hunger return

Conclusion Type 2 diabetes medications can feel overwhelming at first so many names, so many options